Subscribe To

Price Alert Latest News Economic Calendar News

NUMIF / Numinus Wellness welcomes three key advisors to its new bioscience advisory board

Numinus Wellness Inc. (TSX-V:NUMI, OTC:LKYSF) has appointed three key advisors –Graham Pechenik, Paul Spagnuolo, and Cory Harris–to its new bioscience advisory board. The new bioscience advisory board will contribute strategically to advancing Numinus' IP strategy, including product development and clinical trial activities out of the company's Health Canada-licensed research facility, Numinus Bioscience. Read More

Demo Live Account See Partner Details

Content Topics

Middlefield

Healthcare

Dividend

Etf

Ls

To

Numinus

Wellness

Welcomes

Advisors

Bioscience

Advisory

Stock

NUMIF

Posted: Feb 1 2022, 09:15

Author Name: Proactive Investors

NUMIF News

By Proactive Investors
October 3, 2023

Numinus Wellness launches psychedelic program for mental distress associated with serious illness

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) has announced a comprehensive psychedelic program for patients with mental distress associated with seriou

By Proactive Investors
September 19, 2023

Numinus Wellness takes strategic measures to accelerate toward profitability

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) said it is taking several actions to reduce its cash expenses that are expected to save nearly C$1 million

By Proactive Investors
September 19, 2023

Numinus Wellness takes action to accelerate path to profitability

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) has announced a number of measures aimed at reducing costs as it focuses on its positive cash flow-gener

By Seeking Alpha
July 17, 2023

Numinus Wellness Inc. (NUMIF) Q3 2023 Earnings Call Transcript

Numinus Wellness Inc. (OTCQX:NUMIF) Q3 2023 Earnings Conference Call July 17, 2023 5:30 PM ET Company Participants Jamie Kokoska - VP, IR Payton Nyquv

By Proactive Investors
July 17, 2023

Numinus Wellness sees its 3Q revenue soar on client appointment growth

Numinus Wellness Inc announced that its third-quarter 2023 revenue surged 713.3% year-over-year to C$6.0 million, while rising 12.6% sequentially,

By PRNewsWire
July 10, 2023

Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023

VANCOUVER, BC , July 10, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) – a mental health care c

By Proactive Investors
June 22, 2023

Numinus Wellness announces partnership with HealingMaps

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) has announced a partnership with HealingMaps, a leading source of accurate information about psychedelic-a

By Proactive Investors
June 15, 2023

Numinus Wellness reveals partnership with the Multidisciplinary Association for Psychedelic Studies

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) revealed that it has partnered with the Multidisciplinary Association for Psychedelic Studies (MAPS) to s

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.